Search

Search Constraints

You searched for: Author/Creator Fox, Edward J.

Search Results

3. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. (12th September 2017)

4. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. (12th September 2017)

5. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study. (6th October 2020)

10. Parkinson's Progression Markers Initiative brain autopsy program. (August 2022)